Mass vaccination with CoviVac to be launched in spring
- 20 February 2021
Mass inoculation against COVID-19 with the CoviVac vaccine developed by the Chumakov Federal Scientific Center for the Research and Development of Immune and Biological Products is scheduled to begin in spring, Russian Science and Higher Education Minister Valery Falkov said on Saturday, APA reports citing TASS.
According to Falkov, the third phase of CoviVac trials is scheduled for March, 3,000 people will take part in it.
The minister noted that "in 2020, when the world was confronted with the coronavirus pandemic, society reconsidered its views of the importance of scientific activities, the importance of scientists’ work." He stressed that "Russian science once again proved its superiority by creating the world’s first coronavirus vaccine."